Dr. Anna Mirzoyan, MD

Dr. Mirzoyan practices at Permanente Medical Group Inc in Stockton, California.

Dr. Mirzoyan's NPI, 1053463281, was assigned on January 17, 2007. Dr. Mirzoyan graduated from Yerevan State Medical University in 1983. Dr. Mirzoyan holds California license A96677.

Dr. Mirzoyan's primary practice is Permanente Medical Group Inc, at 7373 West Ln, Stockton, CA 95210 in San Joaquin County. The practice phone is (209) 476-2000.

Dr. Mirzoyan's primary practice is Permanente Medical Group Inc in Stockton, California. Dr. Mirzoyan is also affiliated with Sacramento Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Mirzoyan to 2 more hospices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirzoyan practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Mirzoyan's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Mirzoyan is board certified in family medicine by the American Board of Family Medicine. Dr. Mirzoyan is licensed in California.

Dmand AI lists adjustment disease, aortic atherosclerois, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD), lower back pain, muscle pain, fibromyalgia, and limb pain and peripheral vascular disease among the conditions Dr. Mirzoyan treats.

CMS data shows 24 Medicare services from Dr. Mirzoyan across 1 procedure code in 2024, all of them office visits, for 21 Medicare patients. Medicare paid $1,141 for them. Every service was in an office.

CMS counts 21 Medicare patients who saw Dr. Mirzoyan in 2024. 71% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 0.81, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mirzoyan's median patient age at 61, with 69% women.

In 2024, Dr. Mirzoyan wrote 9,088 Medicare Part D claims for 835 patients. 91% of them were for generic drugs. CMS names the drug for 8,445 of them, across 136 drugs with 11 or more claims each, at $341,956 in total drug cost. In 2023, CMS named 8,772 claims across 141 drugs.

Dr. Mirzoyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirzoyan as offering telehealth.

Dr. Mirzoyan graduated from Yerevan State Medical University in 1983.

Dr. Mirzoyan is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.